Loading…

Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)

To test the hypothesis that the accumulation of oxidized phospholipids (OxPL) in the macula is toxic to the retina unless neutralized by a variety of mechanisms, including binding by lipoprotein(a) [Lp(a)], which is composed of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB). Human macula...

Full description

Saved in:
Bibliographic Details
Published in:Transactions of the American Ophthalmological Society 2015, Vol.113, p.T5-T5
Main Authors: Handa, James T, Tagami, Mizuki, Ebrahimi, Katayoon, Leibundgut, Gregor, Janiak, Anna, Witztum, Joseph L, Tsimikas, Sotirios
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page T5
container_issue
container_start_page T5
container_title Transactions of the American Ophthalmological Society
container_volume 113
creator Handa, James T
Tagami, Mizuki
Ebrahimi, Katayoon
Leibundgut, Gregor
Janiak, Anna
Witztum, Joseph L
Tsimikas, Sotirios
description To test the hypothesis that the accumulation of oxidized phospholipids (OxPL) in the macula is toxic to the retina unless neutralized by a variety of mechanisms, including binding by lipoprotein(a) [Lp(a)], which is composed of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB). Human maculas and eyes from two Lp(a) transgenic murine models were subjected to morphologic, ultrastructural, and immunohistochemical analysis. "Wild-type Lp(a)" mice, which express human apoB-100 and apo(a) that contains oxidized phospholipid, and "mutant LBS(-) Lp(a)" mice with a defective apo(a) lysine binding site (LBS) for oxidized phospholipid binding, were fed a chow or high-fat diet for 2 to 12 months. Oxidized phospholipid-containing lipoproteins were detected by immunoreactivity to E06, a murine monoclonal antibody binding to the phosphocholine headgroup of oxidized, but not native, phospholipids. Oxidized phospholipids, apo(a), and apoB accumulate in maculas, including drusen, of age-related macular degeneration (AMD) samples and age-matched controls. Lp(a) mice fed a high-fat diet developed age-related changes. However, mutant LBS(-) Lp(a) mice fed a high-fat diet developed retinal pigment epithelial cell degeneration and drusen. These changes were associated with increased OxPL, decreased antioxidant defenses, increased complement, and decreased complement regulators. Human maculas accumulate Lp(a) and OxPL. Mutant LBS(-) Lp(a) mice, lacking the ability to bind E06-detectable oxidized phospholipid, develop AMD-like changes. The ability of Lp(a) to bind E06-detectable OxPL may play a protective role in AMD.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4601905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1731781686</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1115-dd20d0a0d5f7ef17ee0e594409996be7eb65354ac973af37174be75e5b47a0c33</originalsourceid><addsrcrecordid>eNpVkUFv1DAQhSMEokvhL6A5bg-R7DqONxekUFqotFWrtpyjWWc2GeTYwfaC9k_xGwmiIDiN9ObN-6R5z4qV1JUuaynF82IlRK3LRit1UrxK6YsQyihZvyxOzmutNsZUq-LHlucwx5CJ_bo9g--cR2g9XPuMNsP2mNgTvGffsx_ggTPB3S-3zQnySHBPmT3CVQwToId2oPKeHGbq4QbtwWGEDzSQp4iZg4e7kXzIx5mAPdywJVgvtHaiyHa5v53HPKKbggvDIjh4CJYpH-FxpMTp7HXxYo8u0ZuneVp8vrp8vPhUbm8_Xl-023KWUuqy789FL1D0em9oLw2RIN1UlWiapt6Rod3yAF2hbYzCvTLSVIuqSe8qg8IqdVq8-507H3YT9ZZ8jui6OfKE8dgF5O7_jeexG8K3rqqFbIReAtZPATF8PVDK3cTJknPoKRxSJ5cmzEbWm3qxvv2X9RfypyT1E6rrkec</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1731781686</pqid></control><display><type>article</type><title>Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)</title><source>PubMed Central</source><creator>Handa, James T ; Tagami, Mizuki ; Ebrahimi, Katayoon ; Leibundgut, Gregor ; Janiak, Anna ; Witztum, Joseph L ; Tsimikas, Sotirios</creator><creatorcontrib>Handa, James T ; Tagami, Mizuki ; Ebrahimi, Katayoon ; Leibundgut, Gregor ; Janiak, Anna ; Witztum, Joseph L ; Tsimikas, Sotirios</creatorcontrib><description>To test the hypothesis that the accumulation of oxidized phospholipids (OxPL) in the macula is toxic to the retina unless neutralized by a variety of mechanisms, including binding by lipoprotein(a) [Lp(a)], which is composed of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB). Human maculas and eyes from two Lp(a) transgenic murine models were subjected to morphologic, ultrastructural, and immunohistochemical analysis. "Wild-type Lp(a)" mice, which express human apoB-100 and apo(a) that contains oxidized phospholipid, and "mutant LBS(-) Lp(a)" mice with a defective apo(a) lysine binding site (LBS) for oxidized phospholipid binding, were fed a chow or high-fat diet for 2 to 12 months. Oxidized phospholipid-containing lipoproteins were detected by immunoreactivity to E06, a murine monoclonal antibody binding to the phosphocholine headgroup of oxidized, but not native, phospholipids. Oxidized phospholipids, apo(a), and apoB accumulate in maculas, including drusen, of age-related macular degeneration (AMD) samples and age-matched controls. Lp(a) mice fed a high-fat diet developed age-related changes. However, mutant LBS(-) Lp(a) mice fed a high-fat diet developed retinal pigment epithelial cell degeneration and drusen. These changes were associated with increased OxPL, decreased antioxidant defenses, increased complement, and decreased complement regulators. Human maculas accumulate Lp(a) and OxPL. Mutant LBS(-) Lp(a) mice, lacking the ability to bind E06-detectable oxidized phospholipid, develop AMD-like changes. The ability of Lp(a) to bind E06-detectable OxPL may play a protective role in AMD.</description><identifier>ISSN: 0065-9533</identifier><identifier>EISSN: 1545-6110</identifier><identifier>PMID: 26538774</identifier><language>eng</language><publisher>United States: The American Ophthalmological Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Animals ; Apolipoproteins A - metabolism ; Apolipoproteins B - metabolism ; Binding Sites ; Disease Models, Animal ; Female ; Humans ; Immunohistochemistry ; Lipoprotein(a) - metabolism ; Lysine - metabolism ; Macula Lutea - metabolism ; Macular Degeneration - metabolism ; Macular Degeneration - physiopathology ; Male ; Mice ; Mice, Transgenic ; Middle Aged ; Oxidation-Reduction ; Oxidative Stress - physiology ; Phenotype ; Phospholipids - metabolism ; Retina - metabolism</subject><ispartof>Transactions of the American Ophthalmological Society, 2015, Vol.113, p.T5-T5</ispartof><rights>2015 by the American Ophthalmological Society 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601905/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601905/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26538774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Handa, James T</creatorcontrib><creatorcontrib>Tagami, Mizuki</creatorcontrib><creatorcontrib>Ebrahimi, Katayoon</creatorcontrib><creatorcontrib>Leibundgut, Gregor</creatorcontrib><creatorcontrib>Janiak, Anna</creatorcontrib><creatorcontrib>Witztum, Joseph L</creatorcontrib><creatorcontrib>Tsimikas, Sotirios</creatorcontrib><title>Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)</title><title>Transactions of the American Ophthalmological Society</title><addtitle>Trans Am Ophthalmol Soc</addtitle><description>To test the hypothesis that the accumulation of oxidized phospholipids (OxPL) in the macula is toxic to the retina unless neutralized by a variety of mechanisms, including binding by lipoprotein(a) [Lp(a)], which is composed of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB). Human maculas and eyes from two Lp(a) transgenic murine models were subjected to morphologic, ultrastructural, and immunohistochemical analysis. "Wild-type Lp(a)" mice, which express human apoB-100 and apo(a) that contains oxidized phospholipid, and "mutant LBS(-) Lp(a)" mice with a defective apo(a) lysine binding site (LBS) for oxidized phospholipid binding, were fed a chow or high-fat diet for 2 to 12 months. Oxidized phospholipid-containing lipoproteins were detected by immunoreactivity to E06, a murine monoclonal antibody binding to the phosphocholine headgroup of oxidized, but not native, phospholipids. Oxidized phospholipids, apo(a), and apoB accumulate in maculas, including drusen, of age-related macular degeneration (AMD) samples and age-matched controls. Lp(a) mice fed a high-fat diet developed age-related changes. However, mutant LBS(-) Lp(a) mice fed a high-fat diet developed retinal pigment epithelial cell degeneration and drusen. These changes were associated with increased OxPL, decreased antioxidant defenses, increased complement, and decreased complement regulators. Human maculas accumulate Lp(a) and OxPL. Mutant LBS(-) Lp(a) mice, lacking the ability to bind E06-detectable oxidized phospholipid, develop AMD-like changes. The ability of Lp(a) to bind E06-detectable OxPL may play a protective role in AMD.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Animals</subject><subject>Apolipoproteins A - metabolism</subject><subject>Apolipoproteins B - metabolism</subject><subject>Binding Sites</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Lipoprotein(a) - metabolism</subject><subject>Lysine - metabolism</subject><subject>Macula Lutea - metabolism</subject><subject>Macular Degeneration - metabolism</subject><subject>Macular Degeneration - physiopathology</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Middle Aged</subject><subject>Oxidation-Reduction</subject><subject>Oxidative Stress - physiology</subject><subject>Phenotype</subject><subject>Phospholipids - metabolism</subject><subject>Retina - metabolism</subject><issn>0065-9533</issn><issn>1545-6110</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVkUFv1DAQhSMEokvhL6A5bg-R7DqONxekUFqotFWrtpyjWWc2GeTYwfaC9k_xGwmiIDiN9ObN-6R5z4qV1JUuaynF82IlRK3LRit1UrxK6YsQyihZvyxOzmutNsZUq-LHlucwx5CJ_bo9g--cR2g9XPuMNsP2mNgTvGffsx_ggTPB3S-3zQnySHBPmT3CVQwToId2oPKeHGbq4QbtwWGEDzSQp4iZg4e7kXzIx5mAPdywJVgvtHaiyHa5v53HPKKbggvDIjh4CJYpH-FxpMTp7HXxYo8u0ZuneVp8vrp8vPhUbm8_Xl-023KWUuqy789FL1D0em9oLw2RIN1UlWiapt6Rod3yAF2hbYzCvTLSVIuqSe8qg8IqdVq8-507H3YT9ZZ8jui6OfKE8dgF5O7_jeexG8K3rqqFbIReAtZPATF8PVDK3cTJknPoKRxSJ5cmzEbWm3qxvv2X9RfypyT1E6rrkec</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Handa, James T</creator><creator>Tagami, Mizuki</creator><creator>Ebrahimi, Katayoon</creator><creator>Leibundgut, Gregor</creator><creator>Janiak, Anna</creator><creator>Witztum, Joseph L</creator><creator>Tsimikas, Sotirios</creator><general>The American Ophthalmological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2015</creationdate><title>Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)</title><author>Handa, James T ; Tagami, Mizuki ; Ebrahimi, Katayoon ; Leibundgut, Gregor ; Janiak, Anna ; Witztum, Joseph L ; Tsimikas, Sotirios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1115-dd20d0a0d5f7ef17ee0e594409996be7eb65354ac973af37174be75e5b47a0c33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Animals</topic><topic>Apolipoproteins A - metabolism</topic><topic>Apolipoproteins B - metabolism</topic><topic>Binding Sites</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Lipoprotein(a) - metabolism</topic><topic>Lysine - metabolism</topic><topic>Macula Lutea - metabolism</topic><topic>Macular Degeneration - metabolism</topic><topic>Macular Degeneration - physiopathology</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Middle Aged</topic><topic>Oxidation-Reduction</topic><topic>Oxidative Stress - physiology</topic><topic>Phenotype</topic><topic>Phospholipids - metabolism</topic><topic>Retina - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Handa, James T</creatorcontrib><creatorcontrib>Tagami, Mizuki</creatorcontrib><creatorcontrib>Ebrahimi, Katayoon</creatorcontrib><creatorcontrib>Leibundgut, Gregor</creatorcontrib><creatorcontrib>Janiak, Anna</creatorcontrib><creatorcontrib>Witztum, Joseph L</creatorcontrib><creatorcontrib>Tsimikas, Sotirios</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transactions of the American Ophthalmological Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Handa, James T</au><au>Tagami, Mizuki</au><au>Ebrahimi, Katayoon</au><au>Leibundgut, Gregor</au><au>Janiak, Anna</au><au>Witztum, Joseph L</au><au>Tsimikas, Sotirios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)</atitle><jtitle>Transactions of the American Ophthalmological Society</jtitle><addtitle>Trans Am Ophthalmol Soc</addtitle><date>2015</date><risdate>2015</risdate><volume>113</volume><spage>T5</spage><epage>T5</epage><pages>T5-T5</pages><issn>0065-9533</issn><eissn>1545-6110</eissn><abstract>To test the hypothesis that the accumulation of oxidized phospholipids (OxPL) in the macula is toxic to the retina unless neutralized by a variety of mechanisms, including binding by lipoprotein(a) [Lp(a)], which is composed of apolipoprotein(a) [apo(a)] and apolipoprotein B-100 (apoB). Human maculas and eyes from two Lp(a) transgenic murine models were subjected to morphologic, ultrastructural, and immunohistochemical analysis. "Wild-type Lp(a)" mice, which express human apoB-100 and apo(a) that contains oxidized phospholipid, and "mutant LBS(-) Lp(a)" mice with a defective apo(a) lysine binding site (LBS) for oxidized phospholipid binding, were fed a chow or high-fat diet for 2 to 12 months. Oxidized phospholipid-containing lipoproteins were detected by immunoreactivity to E06, a murine monoclonal antibody binding to the phosphocholine headgroup of oxidized, but not native, phospholipids. Oxidized phospholipids, apo(a), and apoB accumulate in maculas, including drusen, of age-related macular degeneration (AMD) samples and age-matched controls. Lp(a) mice fed a high-fat diet developed age-related changes. However, mutant LBS(-) Lp(a) mice fed a high-fat diet developed retinal pigment epithelial cell degeneration and drusen. These changes were associated with increased OxPL, decreased antioxidant defenses, increased complement, and decreased complement regulators. Human maculas accumulate Lp(a) and OxPL. Mutant LBS(-) Lp(a) mice, lacking the ability to bind E06-detectable oxidized phospholipid, develop AMD-like changes. The ability of Lp(a) to bind E06-detectable OxPL may play a protective role in AMD.</abstract><cop>United States</cop><pub>The American Ophthalmological Society</pub><pmid>26538774</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0065-9533
ispartof Transactions of the American Ophthalmological Society, 2015, Vol.113, p.T5-T5
issn 0065-9533
1545-6110
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4601905
source PubMed Central
subjects Adult
Aged
Aged, 80 and over
Animals
Apolipoproteins A - metabolism
Apolipoproteins B - metabolism
Binding Sites
Disease Models, Animal
Female
Humans
Immunohistochemistry
Lipoprotein(a) - metabolism
Lysine - metabolism
Macula Lutea - metabolism
Macular Degeneration - metabolism
Macular Degeneration - physiopathology
Male
Mice
Mice, Transgenic
Middle Aged
Oxidation-Reduction
Oxidative Stress - physiology
Phenotype
Phospholipids - metabolism
Retina - metabolism
title Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T17%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipoprotein(A)%20with%20An%20Intact%20Lysine%20Binding%20Site%20Protects%20the%20Retina%20From%20an%20Age-Related%20Macular%20Degeneration%20Phenotype%20in%20Mice%20(An%20American%20Ophthalmological%20Society%20Thesis)&rft.jtitle=Transactions%20of%20the%20American%20Ophthalmological%20Society&rft.au=Handa,%20James%20T&rft.date=2015&rft.volume=113&rft.spage=T5&rft.epage=T5&rft.pages=T5-T5&rft.issn=0065-9533&rft.eissn=1545-6110&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1731781686%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1115-dd20d0a0d5f7ef17ee0e594409996be7eb65354ac973af37174be75e5b47a0c33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1731781686&rft_id=info:pmid/26538774&rfr_iscdi=true